Ypsomed autoinjector
Our autoinjector YpsoMate is launched on the market by renowned biotech companies.

YpsoMate's platform approach is paying off

YpsoStories

Several customers have recently launched their autoinjectors based on our YpsoMate platform product technology on the market. Customers value the fast product customisation as well as the individual design possibilities. End users appreciate its user-friendliness.

Topics:

Logistics in the medical sector
Marlene Flück, Head of Import/Export

Internationality places high demands on logistics

YpsoStories

For a globally operating medical devices company, there are many difficulties, barriers and insecurities in the worldwide supply of medical products, which pose challenges for logistics. Challenges that our logistics department masters on a daily basis.

Topics:

Digitisation in diabetes therapy management

Changing patient-doctor relationship

YpsoStories

Digitisation opens the door for new products and new possibilities in the diabetes therapy management. Due to digitisation, patients are gaining knowledge and independence and therefore their demands increase. As a result, the patient-doctor relationship is undergoing change.

Topics:

Individualisation in diabetes therapy

YpsoStories

The number of Type 1 diabetics using old insulin pumps without secure communication interfaces to build their own “Closed Loop” system is growing steadily. The so-called “loopers” are thus sending a clear signal to manufacturers and showing what is in demand for insulin pump therapy.

Topics:

Increasing demand for flexible volumes

YpsoStories

New, specific drugs for a variety of autoimmune diseases are penetrating the market. This leads to changes: numerous new drug manufacturers, many new drugs and new requirements for injection systems. If you want to be one of the players, you have to be flexible and adapt your production concepts accordingly.

Topics: